GlassScriptPhysician profile
James R Allen
NPI 1659369858
$2,479.68
in general payments reported to CMS, 2019-2025
17 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $584 · 2021: $198 · 2022: $431 · 2023: $498 · 2024: $159 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,042.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $1,263.08 | 2020-2025 | Optune, Optune Gio |
| Gt Medical Technologies, INC | $497.72 | 2022-2025 | Gammatile |
| Pfizer INC. | $140.65 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $108.93 | 2019-2023 | Imfinzi |
| Janssen Biotech, INC. | $71.42 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $70.27 | 2020-2023 | Imbruvica |
| Insmed, INC. | $60.37 | 2025 | Brinsupri, Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $56.61 | 2019-2023 | Vonvendi |
| Regeneron Healthcare Solutions, INC. | $39.25 | 2023 | Libtayo |
| Genzyme Corporation | $36.62 | 2019-2022 | |
| Zap Surgical Systems, INC. | $34.53 | 2022 | |
| Amgen INC. | $21.25 | 2022 | |
| Lilly USA, LLC | $18.47 | 2023 | Jardiance |
| Medtronic, INC. | $17.03 | 2023 | Osteocool Rf Ablation System |
| Emd Serono, INC. | $16.74 | 2023 | Bavencio |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.92 | 2023 | |
| Taiho Oncology, INC. | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.